TrialBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects.

Hong Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.